Chemoinformaics analysis of E-6-O-P-METHOXYCINNAMOYL SCANDOSIDE METHYL ESTER
| Molecular Weight | 564.54 | nRot | 9 |
| Heavy Atom Molecular Weight | 532.284 | nRig | 25 |
| Exact Molecular Weight | 564.184 | nRing | 4 |
| Solubility: LogS | -1.678 | nHRing | 2 |
| Solubility: LogP | 0.301 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 72 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 40 | No. of Aromatic Carbocycles | 1 |
| nHetero | 13 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 13 | No. of Arom Bond | 6 |
| nHA | 13 | APOL | 76.8534 |
| nHD | 5 | BPOL | 44.2546 |
| QED | 0.14 |
| Synth | 4.786 |
| Natural Product Likeliness | 2.112 |
| NR-PPAR-gamma | 0.03 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.454 |
| HIA | 0.978 |
| CACO-2 | -5.839 |
| MDCK | 0.000122643 |
| BBB | 0.519 |
| PPB | 0.398338 |
| VDSS | 0.388 |
| FU | 0.281432 |
| CYP1A2-inh | 0.012 |
| CYP1A2-sub | 0.053 |
| CYP2c19-inh | 0.044 |
| CYP2c19-sub | 0.275 |
| CYP2c9-inh | 0.011 |
| CYP2c9-sub | 0.082 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.199 |
| CYP3a4-inh | 0.14 |
| CYP3a4-sub | 0.232 |
| CL | 1.715 |
| T12 | 0.42 |
| hERG | 0.051 |
| Ames | 0.747 |
| ROA | 0.388 |
| SkinSen | 0.032 |
| Carcinogencity | 0.794 |
| EI | 0.006 |
| Respiratory | 0.854 |
| NR-Aromatase | 0.036 |
| Antiviral | Yes |
| Prediction | 0.86548 |